Bridgewater Associates LP Reduces Position in Option Care Health, Inc. (NASDAQ:OPCH)

Bridgewater Associates LP lessened its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 87.7% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 26,706 shares of the company's stock after selling 190,886 shares during the quarter. Bridgewater Associates LP's holdings in Option Care Health were worth $836,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of OPCH. UMB Bank n.a. increased its holdings in Option Care Health by 937.5% during the 3rd quarter. UMB Bank n.a. now owns 830 shares of the company's stock worth $26,000 after purchasing an additional 750 shares in the last quarter. GAMMA Investing LLC raised its stake in Option Care Health by 110.6% in the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company's stock valued at $28,000 after acquiring an additional 471 shares during the period. Whittier Trust Co. of Nevada Inc. increased its stake in shares of Option Care Health by 3,362.8% in the third quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company's stock worth $47,000 after purchasing an additional 1,446 shares in the last quarter. Blue Trust Inc. raised its position in shares of Option Care Health by 14.8% in the second quarter. Blue Trust Inc. now owns 2,931 shares of the company's stock valued at $81,000 after purchasing an additional 377 shares during the period. Finally, International Assets Investment Management LLC grew its stake in Option Care Health by 3,029.7% in the 3rd quarter. International Assets Investment Management LLC now owns 2,848 shares of the company's stock valued at $91,000 after buying an additional 2,757 shares in the last quarter. Institutional investors and hedge funds own 98.05% of the company's stock.

Insiders Place Their Bets

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of the business's stock in a transaction on Friday, November 8th. The stock was acquired at an average cost of $22.54 per share, for a total transaction of $969,220.00. Following the completion of the transaction, the director now directly owns 326,334 shares in the company, valued at approximately $7,355,568.36. This represents a 15.18 % increase in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Corporate insiders own 0.64% of the company's stock.

Option Care Health Price Performance

OPCH stock traded up $0.32 during midday trading on Monday, reaching $24.12. The company had a trading volume of 2,276,178 shares, compared to its average volume of 1,549,572. Option Care Health, Inc. has a 1 year low of $21.39 and a 1 year high of $34.63. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The company has a market capitalization of $4.10 billion, a P/E ratio of 20.27, a P/E/G ratio of 2.46 and a beta of 1.32. The firm has a 50-day moving average price of $26.84 and a 200-day moving average price of $28.87.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the company. Truist Financial cut their target price on Option Care Health from $41.00 to $34.00 and set a "buy" rating for the company in a research note on Friday, November 1st. JMP Securities boosted their price objective on shares of Option Care Health from $36.00 to $37.00 and gave the company a "market outperform" rating in a research note on Monday, September 30th. Barrington Research lowered their target price on shares of Option Care Health from $40.00 to $32.00 and set an "outperform" rating on the stock in a research note on Thursday, October 31st. Jefferies Financial Group lowered shares of Option Care Health from a "buy" rating to a "hold" rating and reduced their price target for the company from $38.00 to $26.00 in a research report on Thursday, October 31st. Finally, Bank of America cut shares of Option Care Health from a "buy" rating to a "neutral" rating and decreased their price target for the stock from $43.00 to $29.00 in a report on Wednesday, October 30th. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $30.83.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.